Global e-commerce sneaker startup KICK CREW has raised a Series A round while Chinese clinical-stage biotech firm InxMed has secured $50 million in a Series B round.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
